What Researchers Did
Researchers investigated the effects of 60 daily hyperbaric oxygen therapy (HBOT) sessions on telomere length and senescent cell concentrations in 35 healthy adults aged 64 and older.
What They Found
Telomere length in T helper, T cytotoxic, natural killer, and B cells significantly increased by over 20% following hyperbaric oxygen therapy (HBOT). Specifically, B cell telomere length increased by 25.68% at session 30, 29.39% at session 60, and 37.63% post-HBOT. The study also found a significant decrease in senescent T helper cells by 37.30% and T-cytotoxic cells by 10.96% after HBOT.
What This Means for Canadian Patients
Hyperbaric oxygen therapy (HBOT) could potentially offer a non-pharmacological approach to mitigate cellular aging and improve overall physiological capacity in older Canadian patients. This therapy might help reduce age-related cellular decline, potentially contributing to a healthier aging process.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's relatively small sample size of 35 participants limits the generalizability of the findings.